Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
easily crosses the blood-brain barrier
Who Should NOT Use BPC-157 Pregnant or breastfeeding women insufficient safety data Active or recent cancer theoretical angiogenesis concern Uncontrolled bleeding disorders Known peptide allergy Uncontrolled severe cardiovascular disease without specialist clearance Drug Interactions Formal interaction data is limited
efficacy pathways respond to cumulative exposure over time
Nevertheless, after intervention with GHK-Cu, a significant reduction in these pathological changes was observed (Figures 2DG)
Zudem wirkt es modulierend auf Entzndungsprozesse
Thus, nanoparticles with lipophilic properties can cross the BBB more efficiently and are able to deliver drug molecules adequately into the brain parenchyma[71, 72]
